LINC02390

Across TCGA pan-cancer cohorts, LINC02390 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC02390 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC02390 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02390 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

LUAD, KIRC, and BLCA are the cancer types where LINC02390 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.780	0.609	<.001	96	view →
KIRC	DFS	Quartile	II,III,IV	0.327	0.601	<.001	61	view →
BLCA	OS	Median	IV	0.686	0.500	.004	58	view →
THCA	OS	Quartile	II,III,IV	0.950	1.000	.001	46	view →
SKCM	OS	Tertile	All	0.954	0.795	<.001	42	view →
CESC	OS	Tertile	All	0.870	0.719	.003	34	view →
BRCA	DFS	Tertile	All	0.628	0.493	.002	21	view →
KIRP	DFS	Tertile	III,IV	0.231	0.722	.008	18	view →
HNSC	DFS	Quartile	All	0.777	0.666	.007	17	view →
LUSC	OS	Median	All	0.808	0.711	.004	14	view →
COAD	DFS	Quartile	II,III,IV	0.643	0.429	.013	13	view →
LIHC	DFS	Quartile	All	0.353	0.577	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC02390–LUAD (OS)

Open the LUAD breakdown →